Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Ranking and Category
-
148th of 267 in
Pharmacology & Pharmacy
Contents
Current Pharmaceutical Design, Volume 11 - Number 32
Editorial [Hot Topic: Biochemical and Clinical Relevance of Hyperuricaemia (Executive Editor: Dimitri P. Mikhailidis Associate Editor: Stella S. Daskalopoulou)]
, 11(32): 4115 - 4116Stella S. Daskalopoulou and Dimitri P. Mikhailidis
DOI: 10.2174/138161205774913264
Overview of Hyperuricaemia and Gout
, 11(32): 4117 - 4124D. Masseoud, K. Rott, R. Liu-Bryan and C. Agudelo
DOI: 10.2174/138161205774913318
Serum Uric Acid and Risk of Coronary Heart Disease
, 11(32): 4125 - 4132S. G Wannamethee
DOI: 10.2174/138161205774913200
Dietary Factors and Hyperuricaemia
, 11(32): 4133 - 4138Naomi Schlesinger
DOI: 10.2174/138161205774913273
Uric Acid and Oxidative Stress
, 11(32): 4145 - 4151G. K. Glantzounis, E. C. Tsimoyiannis, A. M. Kappas and D. A. Galaris
DOI: 10.2174/138161205774913255
Uric Acid and the Kidney: Urate Transport, Stone Disease and Progressive Renal Failure
, 11(32): 4153 - 4159G. Capasso, Ph. Jaeger, W. G. Robertson and R. J. Unwin
DOI: 10.2174/138161205774913219
Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
, 11(32): 4161 - 4175S. S. Daskalopoulou, V. Tzovaras, D. P. Mikhailidis and M. Elisaf
DOI: 10.2174/138161205774913309
Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
, 11(32): 4177 - 4185Olga Bessmertny, Lauren M. Robitaille and Mitchell S. Cairo
DOI: 10.2174/138161205774913291
Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
, 11(32): 4187 - 4206Cristiano M Francucci, Andrea Camilletti and Marco Boscaro
DOI: 10.2174/138161205774913237
Recent Advances in the Discovery of Tissue Factor/Factor VIIa Inhibitors and Dual Inhibitors of Factor VIIa/Factor Xa
, 11(32): 4207 - 4227A. Kranjc, D. Kikelj and L. Peterlin-Masic
DOI: 10.2174/138161205774913282
Lifelong Endocrine Fluctuations and Related Cognitive Disorders
, 11(32): 4229 - 4252M. L. Ancelin and K. Ritchie
DOI: 10.2174/138161205774913228
   |
Editor-in-Chief
William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
Biography
View Full Editorial Board
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
Biography
Biography of William A. Banks
Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net